JPH10509699A - 医薬組成物 - Google Patents

医薬組成物

Info

Publication number
JPH10509699A
JPH10509699A JP8514302A JP51430295A JPH10509699A JP H10509699 A JPH10509699 A JP H10509699A JP 8514302 A JP8514302 A JP 8514302A JP 51430295 A JP51430295 A JP 51430295A JP H10509699 A JPH10509699 A JP H10509699A
Authority
JP
Japan
Prior art keywords
composition
acid
macrolide
weight
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8514302A
Other languages
English (en)
Japanese (ja)
Inventor
コッタン，シルヴァン
ヘベルリン，バルバラ
セドラニ，リヒャルト
ヴォンデルシェル，ジャッキー
Original Assignee
ノバルティス・アクチエンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9421613A external-priority patent/GB9421613D0/en
Priority claimed from GB9422084A external-priority patent/GB9422084D0/en
Priority claimed from GBGB9425353.1A external-priority patent/GB9425353D0/en
Priority claimed from GBGB9517133.6A external-priority patent/GB9517133D0/en
Application filed by ノバルティス・アクチエンゲゼルシャフト filed Critical ノバルティス・アクチエンゲゼルシャフト
Publication of JPH10509699A publication Critical patent/JPH10509699A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Colloid Chemistry (AREA)
  • Cosmetics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP8514302A 1994-10-26 1995-10-25 医薬組成物 Pending JPH10509699A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB9421613.2 1994-10-26
GB9421613A GB9421613D0 (en) 1994-10-26 1994-10-26 Organic compounds
GB9422084A GB9422084D0 (en) 1994-11-02 1994-11-02 Organic compounds
GB9422084.5 1994-11-02
GB9425353.1 1994-12-15
GBGB9425353.1A GB9425353D0 (en) 1994-12-15 1994-12-15 Organic compounds
GBGB9517133.6A GB9517133D0 (en) 1995-08-22 1995-08-22 Pharmaceutical compositions
GB9517133.6 1995-08-22
PCT/EP1995/004187 WO1996013273A1 (en) 1994-10-26 1995-10-25 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
JPH10509699A true JPH10509699A (ja) 1998-09-22

Family

ID=27451224

Family Applications (3)

Application Number Title Priority Date Filing Date
JP8514302A Pending JPH10509699A (ja) 1994-10-26 1995-10-25 医薬組成物
JP2004245057A Pending JP2004359696A (ja) 1994-10-26 2004-08-25 医薬組成物
JP2005148267A Pending JP2005247870A (ja) 1994-10-26 2005-05-20 医薬組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2004245057A Pending JP2004359696A (ja) 1994-10-26 2004-08-25 医薬組成物
JP2005148267A Pending JP2005247870A (ja) 1994-10-26 2005-05-20 医薬組成物

Country Status (25)

Country Link
EP (2) EP2039358A1 (cg-RX-API-DMAC7.html)
JP (3) JPH10509699A (cg-RX-API-DMAC7.html)
KR (2) KR100518135B1 (cg-RX-API-DMAC7.html)
CN (3) CN1124157C (cg-RX-API-DMAC7.html)
AT (1) ATE411800T1 (cg-RX-API-DMAC7.html)
AU (1) AU714360B2 (cg-RX-API-DMAC7.html)
BR (1) BR9509496A (cg-RX-API-DMAC7.html)
CA (1) CA2200967C (cg-RX-API-DMAC7.html)
CY (1) CY2210B1 (cg-RX-API-DMAC7.html)
CZ (1) CZ289838B6 (cg-RX-API-DMAC7.html)
DE (2) DE19581805T1 (cg-RX-API-DMAC7.html)
ES (1) ES2316150T3 (cg-RX-API-DMAC7.html)
FI (1) FI119497B (cg-RX-API-DMAC7.html)
HU (1) HU225535B1 (cg-RX-API-DMAC7.html)
IL (3) IL129547A (cg-RX-API-DMAC7.html)
MY (1) MY129435A (cg-RX-API-DMAC7.html)
NO (2) NO323078B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ295655A (cg-RX-API-DMAC7.html)
PE (1) PE52896A1 (cg-RX-API-DMAC7.html)
PL (1) PL184368B1 (cg-RX-API-DMAC7.html)
PT (1) PT787011E (cg-RX-API-DMAC7.html)
SK (2) SK285809B6 (cg-RX-API-DMAC7.html)
TR (2) TR199500299A2 (cg-RX-API-DMAC7.html)
TW (1) TW308544B (cg-RX-API-DMAC7.html)
WO (1) WO1996013273A1 (cg-RX-API-DMAC7.html)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11335266A (ja) * 1998-05-11 1999-12-07 Ciba Specialty Chem Holding Inc 医薬最終処方物におけるナノディスパ―ジョンの使用
JP2002193790A (ja) * 2000-12-27 2002-07-10 Lion Corp 水難溶性薬剤含有水中油型エマルジョン及びその製造方法
JP2003503440A (ja) * 1999-06-30 2003-01-28 リポシン インコーポレイテッド 清澄な油を含む薬学的組成物
JP2007517859A (ja) * 2004-01-06 2007-07-05 フリードマン、ドロン 不溶性生物活性物質の経口投与用無水組成物
JP2010163466A (ja) * 2002-07-30 2010-07-29 Wyeth Llc ラパマイシンヒドロキシエステルを含有する非経口製剤
JP2011213733A (ja) * 2000-05-18 2011-10-27 Aeterna Zentaris Gmbh ペプチドの薬剤適用形、その製造法及び使用
JP2012006931A (ja) * 1999-02-26 2012-01-12 Lipocine Inc 疎水性治療剤の改善された送達のための組成物および方法
WO2023139907A1 (ja) * 2022-01-24 2023-07-27 株式会社Moresco 防腐効果を付与したナノエマルジョン

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
NZ280689A (en) * 1995-12-15 1997-08-22 Bernard Charles Sherma Sherman Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
WO1998046268A1 (fr) * 1997-04-11 1998-10-22 Fujisawa Pharmaceutical Co., Ltd. Composition medicamenteuse
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
IN188719B (cg-RX-API-DMAC7.html) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
DE69842121D1 (de) 1997-12-10 2011-03-17 Cyclosporine Therapeutics Ltd Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen
GB2380674B (en) * 1998-03-06 2003-05-28 Novartis Ag Emulsion preconcentrates containing cyclosporin or a macrolide
PL342742A1 (en) * 1998-03-06 2001-07-02 Novartis Ag Emulsion-type pre-concentrates containing cyclosporin or macrolyde
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
JP2002513750A (ja) * 1998-05-07 2002-05-14 エラン コーポレーシヨン ピーエルシー 溶媒／助溶剤を含まないマイクロエマルジョン及びエマルジョンプレ濃縮物のドラッグデリバリーシステム
AR018376A1 (es) * 1998-05-26 2001-11-14 Novartis Ag Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
SE9804192D0 (sv) * 1998-12-03 1998-12-03 Scotia Lipidteknik Ab New formulation
DK1154759T3 (da) 1998-12-30 2008-12-08 Dexcel Ltd Dispergerbart koncentrat til indgift af cyclosporin
ATE283042T1 (de) * 1999-01-28 2004-12-15 Dinesh Shantilal Patel Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel
GB9903547D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
DE60044717D1 (de) 1999-05-10 2010-09-02 Paolo Brenner Kombination von immunsuppressiven substanzen zur behandlung oder vorbeugung von transplantat abstossungen
GB9912476D0 (en) 1999-05-28 1999-07-28 Novartis Ag Organic compounds
DE19925001A1 (de) * 1999-05-31 2000-12-07 Pharma Concepts Gmbh & Co Kg Flüssiges Konzentrat
RU2246293C2 (ru) 1999-06-14 2005-02-20 Космо С.П.А. Фармацевтические композиции для перорального введения с регулируемым высвобождением активного ингредиента и маскируемым вкусом
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
KR100342942B1 (ko) * 1999-07-05 2002-07-02 민경윤 카르두스 마리아누스 추출물 또는 이로부터 정제된 실리빈을함유하는 경구용 마이크로에멀젼 조성물
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US7919113B2 (en) 1999-12-30 2011-04-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dispersible concentrate lipospheres for delivery of active agents
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
IT1318539B1 (it) * 2000-05-26 2003-08-27 Italfarmaco Spa Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente
BR0013813A (pt) * 2000-09-18 2002-04-30 Rpg Life Sciences Ltd Formulação auto-emulsificável possuindo atividades bioabsorventes e imunossupressoras
CZ309178B6 (cs) 2001-02-19 2022-04-20 Novartis Pharma Ag 40-O-(2-hydroxyethyl)rapamycin pro použití při léčení
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
CN1274294C (zh) 2001-10-19 2006-09-13 伊索泰克尼卡股份有限公司 环孢菌素类似物微乳液预浓缩物
CN100346785C (zh) * 2001-10-25 2007-11-07 迪内希尚蒂拉尔·帕特尔 选择性环氧化酶ⅱ抑制剂的新型制剂
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
CN100381175C (zh) * 2004-10-09 2008-04-16 山西中医学院 一种微乳制剂及其制备方法
CN101185638B (zh) * 2004-10-09 2011-04-06 山西中医学院 一种微乳制剂及其制备方法
GB0504950D0 (en) * 2005-03-10 2005-04-20 Novartis Ag Organic compositions
CN1872058B (zh) * 2005-05-31 2011-03-30 华北制药集团新药研究开发有限责任公司 一种含大环内酯类化合物的药物组合物
CA2629245C (en) 2005-11-21 2016-07-12 Novartis Ag Neuroendocrine tumor treatment
US7883855B2 (en) 2006-07-21 2011-02-08 Abbott Laboratories Immunosuppressant drug extraction reagent for immunoassays
CN1919194A (zh) * 2006-08-17 2007-02-28 刘瑜玲 西罗莫司的液体组合物
WO2008082979A2 (en) 2006-12-29 2008-07-10 Abbott Laboratories Diagnostic test for the detection of a molecule or drug in whole blood
JP5319549B2 (ja) 2006-12-29 2013-10-16 アボット・ラボラトリーズ 溶液内捕捉イムノアッセイで使用する非変性細胞溶解試薬
US7914999B2 (en) 2006-12-29 2011-03-29 Abbott Laboratories Non-denaturing lysis reagent
ES2393135T3 (es) 2006-12-29 2012-12-18 Abbott Laboratories Ensayo mejorado para fármacos inmunosupresores
WO2010056754A2 (en) * 2008-11-11 2010-05-20 The Board Regents Of The University Of Texas System Inhibition of mammalian target of rapamycin
US10485792B2 (en) 2009-08-26 2019-11-26 Hadasit Medical Research Services & Development Limited Sustained release delivery systems for the prevention and treatment of head and neck cancers
US10391059B2 (en) 2009-11-11 2019-08-27 Rapamycin Holdings, Inc. Oral rapamycin nanoparticle preparations and use
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
EA201491748A1 (ru) 2012-03-23 2015-02-27 Дзе Юниверсити Оф Квинсленд Иммуномодулирующие средства и способы их применения
WO2014184734A1 (en) 2013-05-14 2014-11-20 Novartis Ag Markers associated with mtor inhibition
WO2015044854A1 (en) 2013-09-24 2015-04-02 Novartis Ag Markers associated with mtor inhibition
CN103933546A (zh) * 2014-03-27 2014-07-23 北京科技大学 雷帕霉素与环孢素a纳米口服微乳液制备方法
JP7459458B2 (ja) * 2018-06-28 2024-04-02 ライオン株式会社 内服組成物及びその製造方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
US3244592A (en) 1962-06-09 1966-04-05 Arai Tadashi Ascomycin and process for its production
GB1380741A (en) * 1971-02-05 1975-01-15 Squibb & Sons Inc Antibiotic compositions and their preparation
GB1322306A (en) * 1971-04-15 1973-07-04 Meiji Seika Co Stabilized antibiotic preparation and manufacturing process therefor
ZA737247B (en) 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
JPS59104326A (ja) * 1982-12-04 1984-06-16 Toyo Jozo Co Ltd マクロライド抗生物質の安定な経口用製剤および安定化法
JPS60163823A (ja) * 1984-02-03 1985-08-26 Taisho Pharmaceut Co Ltd 経口投与製剤
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
AU640963B2 (en) 1989-11-09 1993-09-09 MEDA Pharma S.a.r.l Heteroatoms-containing tricyclic compounds
MY110418A (en) 1990-07-02 1998-05-30 Novartis Ag Heteroatoms-containing tricyclic compounds.
PT98990A (pt) 1990-09-19 1992-08-31 American Home Prod Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
US5120842A (en) 1991-04-01 1992-06-09 American Home Products Corporation Silyl ethers of rapamycin
US5100883A (en) 1991-04-08 1992-03-31 American Home Products Corporation Fluorinated esters of rapamycin
US5118678A (en) 1991-04-17 1992-06-02 American Home Products Corporation Carbamates of rapamycin
US5118677A (en) 1991-05-20 1992-06-02 American Home Products Corporation Amide esters of rapamycin
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
US5151413A (en) 1991-11-06 1992-09-29 American Home Products Corporation Rapamycin acetals as immunosuppressant and antifungal agents
GB9125660D0 (en) 1991-12-03 1992-01-29 Smithkline Beecham Plc Novel compound
HUT66531A (en) 1992-05-07 1994-12-28 Sandoz Ag Heteroatoms-containing tricyclic compounds, pharmaceutical prepns contg. them and process for producing them
DE9208647U1 (de) 1992-06-27 1992-09-24 Rademacher, Antje, 4980 Bünde Stäbchen zur Reinigung von Ohrring-Löchern
ZA935112B (en) 1992-07-17 1994-02-08 Smithkline Beecham Corp Rapamycin derivatives
US5234140A (en) 1992-07-28 1993-08-10 S. C. Johnson & Son, Inc. Re-useable aerosol container
US5256790A (en) 1992-08-13 1993-10-26 American Home Products Corporation 27-hydroxyrapamycin and derivatives thereof
CZ278863B6 (en) * 1992-09-07 1994-07-13 Galena Medicinal preparations with n-methylated cyclic undecapeptides
EP1142568A1 (en) * 1992-09-25 2001-10-10 Novartis AG Pharmaceutical compositions containing cyclosporins
GB9221220D0 (en) 1992-10-09 1992-11-25 Sandoz Ag Organic componds
FR2697040B1 (fr) 1992-10-21 1994-12-30 Ind Entreprise Elément de protection contre le bruit et son utilisation.
US5258389A (en) 1992-11-09 1993-11-02 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DE69426408T2 (de) * 1993-09-28 2001-07-12 Novartis Ag, Basel Herstellung von Weichgelatinekapseln
AU688782B2 (en) * 1993-09-30 1998-03-19 Wyeth Rapamycin formulations for oral administration
EP0729471A1 (en) 1993-11-19 1996-09-04 Abbott Laboratories Semisynthetic analogs of rapamycin (macrolides) being immunomodulators

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11335266A (ja) * 1998-05-11 1999-12-07 Ciba Specialty Chem Holding Inc 医薬最終処方物におけるナノディスパ―ジョンの使用
JP2012006931A (ja) * 1999-02-26 2012-01-12 Lipocine Inc 疎水性治療剤の改善された送達のための組成物および方法
JP2003503440A (ja) * 1999-06-30 2003-01-28 リポシン インコーポレイテッド 清澄な油を含む薬学的組成物
JP2011201914A (ja) * 1999-06-30 2011-10-13 Lipocine Inc 清澄な油を含む薬学的組成物
JP2011213733A (ja) * 2000-05-18 2011-10-27 Aeterna Zentaris Gmbh ペプチドの薬剤適用形、その製造法及び使用
JP2002193790A (ja) * 2000-12-27 2002-07-10 Lion Corp 水難溶性薬剤含有水中油型エマルジョン及びその製造方法
JP2010163466A (ja) * 2002-07-30 2010-07-29 Wyeth Llc ラパマイシンヒドロキシエステルを含有する非経口製剤
JP2007517859A (ja) * 2004-01-06 2007-07-05 フリードマン、ドロン 不溶性生物活性物質の経口投与用無水組成物
WO2023139907A1 (ja) * 2022-01-24 2023-07-27 株式会社Moresco 防腐効果を付与したナノエマルジョン
JPWO2023139907A1 (cg-RX-API-DMAC7.html) * 2022-01-24 2023-07-27

Also Published As

Publication number Publication date
CA2200967A1 (en) 1996-05-09
MY129435A (en) 2007-04-30
NO323078B1 (no) 2006-12-27
FI970995L (fi) 1997-04-25
IL115742A (en) 2000-06-01
FI119497B (fi) 2008-12-15
NO971898L (no) 1997-06-24
DE69535869D1 (de) 2008-12-04
SK286178B6 (sk) 2008-04-07
SK52197A3 (en) 1997-09-10
AU714360B2 (en) 1999-12-23
TW308544B (cg-RX-API-DMAC7.html) 1997-06-21
HUT76858A (en) 1997-12-29
JP2005247870A (ja) 2005-09-15
DE19581805T1 (de) 1997-10-16
TR199501321A2 (tr) 1996-06-21
CZ289838B6 (cs) 2002-04-17
CN1124157C (zh) 2003-10-15
CA2200967C (en) 2007-09-25
AU3924895A (en) 1996-05-23
ES2316150T3 (es) 2009-04-01
MX9702701A (es) 1997-10-31
BR9509496A (pt) 1997-09-30
SK285809B6 (sk) 2007-08-02
ATE411800T1 (de) 2008-11-15
IL115742A0 (en) 1996-01-19
IL129547A0 (en) 2000-02-29
NO323063B1 (no) 2006-12-27
KR20040074104A (ko) 2004-08-21
EP2039358A1 (en) 2009-03-25
TR199500299A2 (tr) 1997-06-23
CN1404833A (zh) 2003-03-26
CY2210B1 (en) 2002-11-08
EP0787011A1 (en) 1997-08-06
NO20031901D0 (no) 2003-04-28
JP2004359696A (ja) 2004-12-24
CZ123197A3 (en) 1997-07-16
IL129547A (en) 2001-01-11
NO971898D0 (no) 1997-04-24
WO1996013273A1 (en) 1996-05-09
NO20031901L (no) 1997-06-24
CN1161652A (zh) 1997-10-08
PE52896A1 (es) 1996-12-12
KR100518135B1 (ko) 2005-10-04
PT787011E (pt) 2009-01-23
KR100541198B1 (ko) 2007-04-11
EP0787011B1 (en) 2008-10-22
PL184368B1 (pl) 2002-10-31
NZ295655A (en) 1998-12-23
CN1679938A (zh) 2005-10-12
KR970706837A (ko) 1997-12-01
FI970995A0 (fi) 1997-03-10
HU225535B1 (en) 2007-02-28
PL319691A1 (en) 1997-08-18

Similar Documents

Publication Publication Date Title
JPH10509699A (ja) 医薬組成物
EP1059913B1 (en) Emulsion preconcentrates containing cyclosporin or a macrolide
US5932243A (en) Galenical formulations
US20110152201A1 (en) Emulsion preconcentrates containing cyclosporin or a macrolide
US20070208075A1 (en) Pharmaceutical compositions
GB2278780A (en) Macrolide antibiotic emulsions
RU2292887C2 (ru) Фармацевтический состав, применение карбоновой кислоты для стабилизации макролида в этом составе и способ стабилизации макролида
RU2181054C2 (ru) Микроэмульсионный предконцентрат
GB2315216A (en) Microemulsion preconcentrates comprising FK 506
CA2513441A1 (en) Pharmaceutical compositions
MXPA97002701A (en) Microemulsion preconcentrates that contain cyclosporine or a macról
HK1034038B (en) Emulsion preconcentrates containing cyclosporin or a macrolide